Patent · US Active

Methods for the determination of compounds or compositions for the treatment of lipofuscin related diseases and compounds or compositions

US10495630B2 · kind B2 · utility

0Cited by

0References

9Claims

0Family size

Assignees

Katairo GmbH · DE
TAKEDA GMBH · DE

Inventors

Ulrich Schraermeyer · Hechingen, DE
Michael Burnet · Bingen, DE
Jorg Senn-Bilfinger · Konstanz, DE
Ernst Sturm · Hillsboro, US
Guido Hanauer · Konstanz, DE

Key dates

Filing date	Feb 13, 2015
Grant date	Dec 3, 2019
Priority date	—
Expiry date	Mar 19, 2035

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/164
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

A method for selecting a compound or a composition suitable for treating lipofuscin associated diseases in a patient, the method including the steps of determining a reactivity factor, determining a targeting factor that allows an uptake into a cell and a provides a targeting of lipofuscin, and selecting a compound or a composition or combining compounds to obtain a compound or composition that comprises a reactivity factor and an targeting factor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.